Roche’s personalized cancer treatment wins FDA approval

The U.S. Food and Drug Administration approved Roche Holding AG's treatment for adult and adolescent patients whose cancers have a genetic defect, the agency said on Thursday. Reuters Health News

https://en.ojaghia.vet

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.